{"filing":{"accession_number":"0001274737-26-000047","cik":"0001274737","ticker":"XGN","company_name":"EXAGEN INC.","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-04","primary_document":"exdx-20260804.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473726000047/exdx-20260804.htm"},"events":[{"id":23929,"run_id":21642,"accession_number":"0001274737-26-000047","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a standard earnings release disclosing quarterly and six-month financial results for the periods ended June 30, 2026. The filing explicitly states \"On August 4, 2026, the Company reported its financial results for the three and six months ended June 30, 2026\" with a press release furnished as Exhibit 99.1. The press release presents revenue ($19.9M for Q2 2026, up 16% YoY), net loss ($3.2M for Q2 2026, down 28% YoY), adjusted EBITDA, and updated full-year guidance ($72-75M), all material metrics for investor assessment.","company_name":"EXAGEN INC.","ticker":"XGN","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":24290,"accession_number":"0001274737-26-000047","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a standard earnings release disclosing quarterly and six-month financial results for the periods ended June 30, 2026. The filing explicitly states \"On August 4, 2026, the Company reported its financial results for the three and six months ended June 30, 2026\" with a press release furnished as Exhibit 99.1. The press release presents revenue ($19.9M for Q2 2026, up 16% YoY), net loss ($3.2M for Q2 2026, down 28% YoY), adjusted EBITDA, and updated full-year guidance ($72-75M), all material metrics for investor assessment.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:31:48.132496+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24290,"accession_number":"0001274737-26-000047","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a standard earnings release disclosing quarterly and six-month financial results for the periods ended June 30, 2026. The filing explicitly states \"On August 4, 2026, the Company reported its financial results for the three and six months ended June 30, 2026\" with a press release furnished as Exhibit 99.1. The press release presents revenue ($19.9M for Q2 2026, up 16% YoY), net loss ($3.2M for Q2 2026, down 28% YoY), adjusted EBITDA, and updated full-year guidance ($72-75M), all material metrics for investor assessment.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:31:48.132496+00:00","company_name":"EXAGEN INC.","ticker":"XGN","filing_date":"2026-08-04"}]}